Jin, C., Deng, J., Jiang, Y., Zhu, J., Kang, L., & Li, S. (2025). BCMA CAR-T therapy as salvage therapy in patients with plasmablastic myeloma. Hematology, 30(1), 1. https://doi.org/10.1080/16078454.2025.2481555
Chicago Style (17th ed.) CitationJin, Chengwei, Jing Deng, Ying Jiang, Jun Zhu, Liqing Kang, and Su Li. "BCMA CAR-T Therapy as Salvage Therapy in Patients with Plasmablastic Myeloma." Hematology 30, no. 1 (2025): 1. https://doi.org/10.1080/16078454.2025.2481555.
MLA (9th ed.) CitationJin, Chengwei, et al. "BCMA CAR-T Therapy as Salvage Therapy in Patients with Plasmablastic Myeloma." Hematology, vol. 30, no. 1, 2025, p. 1, https://doi.org/10.1080/16078454.2025.2481555.
Warning: These citations may not always be 100% accurate.